NCT05828186

Brief Summary

This is a prospective, multicenter, single-arm registry study, aimed to evaluate the clinical outcomes of using Shockwave IVL catheter in the treatment of coronary artery calcification in real-world clinical practice.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started May 2023

Typical duration for all trials

Geographic Reach
1 country

6 active sites

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 1, 2023

Completed
24 days until next milestone

First Posted

Study publicly available on registry

April 25, 2023

Completed
9 days until next milestone

Study Start

First participant enrolled

May 4, 2023

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 9, 2024

Completed
1.4 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

December 5, 2024

Status Verified

December 1, 2024

Enrollment Period

1.3 years

First QC Date

April 1, 2023

Last Update Submit

December 3, 2024

Conditions

Outcome Measures

Primary Outcomes (2)

  • Procedure success

    Procedure success defined as successful stent implantation, residual stenosis degree \<30% (core laboratory), and no major adverse cardiac events (MACE) occurring during hospitalization

    in 48 hours post-procedure or prior to discharge, whichever comes first

  • Freedom from major adverse cardiac events (MACE) within 30 days of the index procedure

    MACE is defined as: Cardiac death; or Myocardial Infarction (MI): Follow the Fourth Universal Definition of Myocardial Infarction ; or Target Vessel Revascularization (TVR) defined as revascularization at the target vessel (inclusive of the target lesion) after the completion of the index procedure; or Target lesion thrombosis.

    30 days post index procedure

Secondary Outcomes (5)

  • Vascular complications in the proudure

    Immediately post index procedure

  • Incidence of target lesion revascularization

    30 days post index procedure

  • Incidence of target lesion revascularization

    6 months post index procedure

  • 30 days post index procedure

    9 months post index procedure

  • Incidence of target lesion revascularization

    12 months post index procedure

Interventions

Patients with coronary artery calcification who are planned to undergo PCI and are deemed in need of Shockwave IVL catheter treatment by their physicians.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All patients with coronary artery calcification who are planned to undergo percutaneous coronary intervention (PCI) and are deemed suitable to receive Shockwave IVL catheter treatment by their physicians.

You may qualify if:

  • Age ≥18 years.
  • Patients with coronary artery calcification who are planned to undergo PCI and are deemed in need of Shockwave IVL catheter treatment by their physicians.
  • The subject or their legal representative agrees to sign the informed consent form.

You may not qualify if:

  • The physician evaluates that the subject's expected lifespan is \<1 year.
  • The subject did not receive IVL treatment in the index procedure.
  • The subject is pregnant or lactating.
  • The subject is currently participating in another clinical study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (6)

liuzhou People's Hospital

Liuchow, Guangxi, China

Location

Yulin First People's Hospital

Yulin, Guangxi, China

Location

The First Affiliated Hospital of Guangxi Medical University

Nanjing, Guanxi, China

Location

Guilin People's Hospital

Guilin, China

Location

Guiping People's Hospital

Guiping, China

Location

Liuzhou labors' Hospital

Liuchow, China

Location

MeSH Terms

Conditions

Coronary Artery DiseaseCalcinosis

Interventions

Catheters

Condition Hierarchy (Ancestors)

Coronary DiseaseMyocardial IschemiaHeart DiseasesCardiovascular DiseasesArteriosclerosisArterial Occlusive DiseasesVascular DiseasesCalcium Metabolism DisordersMetabolic DiseasesNutritional and Metabolic Diseases

Intervention Hierarchy (Ancestors)

Equipment and Supplies

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 1, 2023

First Posted

April 25, 2023

Study Start

May 4, 2023

Primary Completion

August 9, 2024

Study Completion

December 31, 2025

Last Updated

December 5, 2024

Record last verified: 2024-12

Locations